MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Natco Pharma
Natco Pharma
BSE: 524816|NSE: NATCOPHARM|ISIN: INE987B01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 17, 17:00
433.50
-5.7 (-1.3%)
VOLUME 6,280
LIVE
NSE
May 17, 17:00
431.65
-3.75 (-0.86%)
VOLUME 49,698
Management Interviews on Natco Pharma
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
See Rs 20-25cr in revenue/quarter from Lanzoprazol: Natco 

2.44 pm | 14 Feb 2013 |  Source: CNBC-TV18

Hyderabad-based Natco Pharma Limited, on December 21, received the approval from Food & Drug Administration (FDA) for marketing the prescription versi...

1
Quick Links for Natco Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.